PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19: Coronavirus – COVID-19
2021 OCT 22 (NewsRx) -- By a
As a matter of record, on
Tracking Information
Trial Identifier | NCT05075941 |
First Submitted Date | |
First Posted Date | |
Results First Submitted Date | Not Provided |
Results First Posted Date | Not Provided |
Last Update Submitted Date | |
Last Update Posted Date | |
Primary Completion Date | |
Start Date | |
Current Primary Outcome Measures | •Vaccination coverage among COVID-19 [ Time Frame: one month ] -- Assess the proportion of people declaring to have received at least one dose of vaccination against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing |
•Identify the most appropriate conditions for the use of vaccination against COVID-19 [ Time Frame: one month ] -- Promote interventions to encourage the use of COVID-19 vaccination | |
Current Secondary Outcome Measures | Not Provided |
Other Outcome Measures | Not Provided |
Change History | Complete list of historical revisions of study NCT05075941 |
Descriptive Information
Brief Title | Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations |
Official Title | PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 |
Brief Summary | The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : - to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers’ hostels, on the street) with the estimated level in the general population of the same territory obtained from the |
Detailed Description | Not Provided |
Study Type | Observational |
Study Phase | Not Provided |
Study Design | Observational Model: Other |
Time Perspective: Cross-Sectional | |
Condition | COVID-19 |
Intervention | •Other: Vaccination coverage |
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population | |
Study Arms | •Covid Homeless and migrants |
Interventions: | |
⚬Other: Vaccination coverage | |
•Shelters Paris/93 | |
Interventions: | |
⚬Other: Vaccination coverage | |
•Street/Camps Paris/93 | |
Interventions: | |
⚬Other: Vaccination coverage | |
•Workers’ hostels |
|
Interventions: | |
⚬Other: Vaccination coverage | |
•travelling community IDF(77/93/95) | |
Interventions: | |
⚬Other: Vaccination coverage |
Recruitment Information
Recruitment Status | Not yet recruiting |
Estimated Enrollment | 3470 |
Estimated Completion Date | |
Primary Completion Date | |
Eligibility | Inclusion Criteria: |
•Adult (18 years and older) | |
•People considered as homeless (homeless, living in a camp or squat) or | |
•Living in adapted housing (migrant workers’ hostel) or | |
•Housed in residences of the National System or | |
•Housed in a social residence such as a 115 hotel or a social housing centre | |
•Freely and voluntarily consenting to participate Exclusion Criteria: | |
•Refusal to participate in the study (non-consent). | |
•Language barrier with no in-person or telephone translation available. | |
•Impossibility to give free and informed consent (comprehension barrier, cognitive and/or psychiatric and/or addictive disorders, external pressure from family and friends, persons under guardianship, etc.). | |
Sex/Gender | Sexes Eligible for Study: All |
Ages | 18 years and older |
Not Provided | |
Contacts | Primary contact: Thomas ROEDERER, +33 1 40 21 55 55, [email protected] |
Backup contact: Jessica SAYYAD, +33 1 40 21 55 55, [email protected] | |
Listed Location Countries | Not Provided |
Removed Location Countries |
Administrative Information
NCT Number | NCT05075941 |
Other Study ID Numbers | 2021-A01960-41 |
Has Data Monitoring Committee | Not Provided |
Not Provided | |
Plan to Share Data | Yes |
Plan to Share Data (IPD) Description | The results will be presented in a report to the Ministry of Health, the Haute Autorite de |
Epicentre | |
Collaborators | ⚬SANTE PUBLIQUE |
⚬Medecins Sans Frontieres, |
|
⚬Medecins du Monde | |
⚬CROIX ROUGE FRANCAISE | |
⚬OBSERVATOIRE DU SAMU SOCIAL | |
⚬INTERLOGEMENT 93 | |
⚬Agence Regionale de |
|
Investigators | Principal Investigator: Elisabeth POULET, MD, Epicentre |
Information Provided By | Epicentre |
Verification Date |
(Our reports deliver fact-based news of research and discoveries from around the world.)
Insurance, financial services giant The Hartford says workers to begin return to the office in December, in optimistic sign for downtown [Hartford Courant]
KKR Income Opportunities Fund Declares Monthly Distributions of $0.105 Per Share
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News